← Browse by Condition

Medical Condition

pancreatic cancer

Total Trials

40

Recruiting Now

40

Trial Phases

Phase 2, EARLY_Phase 1, Phase 1

NCT06249321 Phase 2

mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy

Fudan University

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

H. Lee Moffitt Cancer Center a...

Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE

NCT04048278 EARLY_Phase 1

Lidocaine Infusion in Pancreatic Cancer

University of Illinois at Chic...

Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

Peking Union Medical College H...

Improving Pancreatic Cancer Care by the Use of Computational Science and Technology

NCT05911217 Phase 1

A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer

CARsgen Therapeutics Co., Ltd.

99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

Nanjing First Hospital, Nanjin...

NCT07349537 Phase 1

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Revolution Medicines, Inc.

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

United States, Austr...

NCT05076760 Phase 1

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

NCT06435260 Phase 2

Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer

Hebei Medical University Fourt...

NCT06941857 Phase 2

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Ca...

Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)

Belgium, Netherlands

University Hospital, Ghent

Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers

Second Affiliated Hospital, Sc...

NCT06819215 Phase 1, Phase 2

Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors

Zhejiang Yangli Pharmaceutical...

NCT06440005 Phase 1

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

NCT02843945 Phase 1, Phase 2

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

CivaTech Oncology

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

NCT06508307 Phase 1

A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors

GONGCHU Biotechnology Co., Ltd

NCT05438667 EARLY_Phase 1

TCR-T Cell Therapy on Advanced Solid Tumors

Sun Yat-Sen Memorial Hospital ...

NCT05093231 Phase 2

Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

Cambridge University Hospitals...

ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer

Insel Gruppe AG, University Ho...

NCT02598349 Phase 2

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Proton Collaborative Group

NCT05827796 Phase 1, Phase 2

IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer

InxMed (Shanghai) Co., Ltd.

NCT05394259 Phase 1

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer

M.D. Anderson Cancer Center

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Hospices Civils de Lyon

NCT06344156 Phase 1

Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer

Sichuan University

NCT06953999 Phase 3

A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer

NCT05472857 Phase 1

Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression

Suzhou Immunofoco Biotechnolog...

A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus

NCT07114315 Phase 2

A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

Familial Investigations of Childhood Cancer Predisposition

St. Jude Children's Research H...

NCT06159478 Phase 2

Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)

National Cancer Center, Japan

NCT06436976 Phase 2

The Effect of Probiotics ATG-F4 in Cancer Patients

Chungnam National University H...

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Denmark, Finland, Fr...

Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.

Origin Sciences

NCT06427460 Phase 2

Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)

Changhai Hospital

NCT06816823 Phase 1

CAR-NK Cells (CL-NK-001) in Pancreatic Cancer

Changhai Hospital

NCT06404840 Phase 2

Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study

Tianjin Medical University Can...